logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
P

Pau Abrisqueta

vall d'hebron university hospital
H指数:37
被引数:5,131

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Exploring the synergy between telomere length and genomic complexity in CLL

探索端粒长度与基因组复杂性在CLL中的协同作用

British Journal of Haematology
IF3.8
2026-01-230
OAAI
Silvia Ramos-Campoy; Anna Puiggros; Joanna Kamaso; Helen Parker; Gian Matteo Rigolin; Claudia Haferlach; María José Larráyoz; Rosa Collado; Rocío Salgado; María José Calasanz; Laurence Etter; Alberto Valiente; Pau Abrisqueta; Francesc Bosch; Eva Gimeno; Antonio Cuneo; Florence Nguyen-Khac; Jacqueline Schoumans; Jonathan C. Strefford; Blanca Espinet
Laboratory Prognostic Index (LAB-PI) in diffuse large B-cell lymphoma: a single blood analysis predicts outcomes as good as IPI, NCCN-IPI, and GELTAMO-IPI☆

弥漫大B细胞淋巴瘤中的实验室预后指数（LAB-PI）：单一血液分析预测结果与IPI、NCCN-IPI和GELTAMO-IPI相当☆

ESMO Open
IF8.3
2025-11-250
OAAI
F. Martin-Moro; L. Bento; J. Marquet; S.F. Browne-Arthur; A. Gutierrez; A. Diaz-Lopez; J. Sanchez-Pina; J.A. Garcia-Vela; A. Salar; R. Cordoba; S. Novelli; M.J. Rodriguez-Salazar; S. Gonzalez De Villambrosia; R. Del Campo; H.D. Luzardo; D. Garcia; J.A. Garcia-Marco; J.M. Sancho; P. Abrisqueta; A. Martin
Fixed-Duration Epcoritamab Plus R2 Drives Favorable Outcomes in Relapsed or Refractory Follicular Lymphoma

固定疗程的Epcoritamab联合R2方案可改善复发或难治性滤泡性淋巴瘤患者的预后。

Blood
IF23.1
2025-09-100
OAAI
Lorenzo Falchi; Anna Sureda; Sirpa Leppä; Joost S.P. Vermaat; Marcel Nijland; Jacob Haaber Christensen; Sven de Vos; Harald Holte; Reid W. Merryman; Pieternella J. Lugtenburg; Pau Abrisqueta; Kim M. Linton; Gauri Sunkersett; Daniela Hoehn; Ali Rana; Aqeel Abbas; Jennifer Marek; Yi Hao; Andrew J. Steele; Christopher Morehouse; Martin Hutchings; David Belada
A phase Ib/II trial combining brentuximab vedotin with cyclophosphamide, procarbazine, prednisone, etoposide and mitoxantrone (BrEPEM) for older patients with untreated classical Hodgkin lymphoma: A multicentre GELTAMO trial

一项Ib/II期临床试验，将brentuximab vedotin与环磷酰胺、丙卡巴肼、泼尼松、依托泊苷和米托蒽醌（BrEPEM）联合用于未经治疗的老年经典型霍奇金淋巴瘤患者：一项多中心GELTAMO试验

British Journal of Haematology
IF3.8
2025-07-250
PRE
Cecilia Carpio; Fátima de la Cruz-Vicente; Ramon García-Sanz; Izaskun Zeberio; Cristina Barrenetxea; Eva Domingo-Domenech; Mariana Bastos; Araceli Rubio Martinez; Pilar Gómez-Prieto; Antonia Rodriguez; Maria Casanova; Antonia Cladera-Serra; Javier Nuñez Cespedes; Carmen Martínez; Miriam Moreno-Velázquez; Eduardo Garcia-Galea; Pau Abrisqueta; Francesc Bosch
TAFASITAMAB PLUS LENALIDOMIDE AS SALVAGE THERAPY IN DIFFUSE LARGE B-CELL LYMPHOMA: REAL-WORLD EXPERIENCE FROM GELTAMO

妥英珠单抗联合来那度胺作为弥漫性大B细胞淋巴瘤的挽救治疗：GELTAMO的真实世界经验

Blood Advances
IF7.1
2025-07-180
OAAI
Antonio Gutierrez; Izaskun Zeberio; Francisco Javier Peñalver; Pilar Martinez-Barranco; Sandra Perez; Daniel Morillo; Xabier Martin; Concepcion Nicolas; Ainara Ferrero; Ana Jimenez-Ubieto; Mariana Bastos-Oreiro; Julio Davila-Valls; Maria Victoria Calle; María Perez; Guillermo Rodriguez; Aranzazu Alonso; Ana Garcia-Noblejas; Diana Sanchez Argüello; Teresa Knight; Ángeles Fernandez; Javier Lopez; Jaime Perez De Oteyza; Sonia González de Villambrosia; Elena Perez; Alejandro Marin; Maria Belen Navarro; Ruben Fernandez; Pilar Gomez; José Antonio Hueso; Maria Jesus Peñarrubia Ponce; Pilar Bravo; Daniel Garcia-Belmonte; Haridian De La Nuez; Sara Nistal; Pau Abrisqueta; Fernanda Ibañez; Luis Palomera; Eva Donato; Andrea Provencio; Maria Stefania Infante; Eva Gonzalez-Barca
Site-specific analysis of extranodal involvement in large B-cell lymphoma reveals distinct efficacy with chimeric antigen receptor T-cell therapy

结外受累的大B细胞淋巴瘤的位点特异性分析揭示了嵌合抗原受体T细胞疗法的独特疗效

LEUKEMIA
IF13.4
2025-04-010
PRE
Iacoboni, Gloria; Rejeski, Kai; Navarro, Victor; van Meerten, Tom; Rampotas, Alex; Martin-Lopez, Ana Africa; Bastos, Mariana; Benzaquen, Ana; Reguera-Ortega, Juan Luis; Carpio, Cecilia; Roddie, Claire; Lopez-Corral, Lucia; Delgado-Serrano, Javier; Landwehr, Maria; Stock, Sophia; de Tena, Pablo Silva; Abrisqueta, Pau; de Boer, Janneke; Martin Garcia-Sancho, Alejandro; Hernani, Rafael; Kwon, Mi; Subklewe, Marion; O'Reilly, Maeve; Barba, Pere
Genetic subtyping by Whole Exome Sequencing across Diffuse Large B Cell Lymphoma and Plasmablastic Lymphoma

通过全外显子测序对弥漫性大B细胞淋巴瘤和浆细胞样淋巴瘤进行遗传亚型分型

PLOS ONE
IF2.6
2025-03-110
OA
Pomares, Aitana Avendano; Merino, Laura Rodriguez; Gonzalez, Sonia; Morata, Jordi; Tonda, Raul; Arribas, Patricia; Revert, Jose; Carrillo, Estrella; Grande, Carlos; Roncero, Josep Maria; de Oteyza, Jaime Perez; Nicolas, Concepcion; Gutierrez, Norma; Abrisqueta, Pau; Gutierrez, Antonio; Ramirez-Payer, Angel; Garcia-Sancho, Alejandro Martin; Gonzalez-Barca, Eva; Montes-Moreno, Santiago
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia and small lymphocytic lymphoma from Chronic Lymphocytic Leukemia Spanish Group (GELLC)

慢性淋巴细胞白血病西班牙小组（GELLC）关于慢性淋巴细胞白血病和小淋巴细胞淋巴瘤的诊断与治疗指南

MEDICINA CLINICA
IF2.1
2025-01-010
PRE
Medina, Angeles; Muntanola, Ana; Crespo, Marta; Ramirez, Angel; Hernandez-Rivas, Jose-angel; Abrisqueta, Pau; de la Serna, Javier; Espinet, Blanca; Gonzalez, Marcos; Loscertales, Javier; Serrano, Alicia; Terol, Maria Jose; Yanez, Lucrecia; Bosch, Francesc
Development and validation of the post-CAR prognostic index for large B-cell lymphoma patients after CAR-T progression in third or later line treatment

大b细胞淋巴瘤患者在三线或更晚线治疗car-t进展后CAR预后指数的开发和验证

JOURNAL OF HEMATOLOGY & ONCOLOGY
IF40.4
2024-10-290
OAAI
Iacoboni, Gloria; Navarro, Victor; Sesques, Pierre; Rejeski, Kai; Bastos-Oreiro, Mariana; Serpenti, Fabio; Martin Lopez, Ana Africa; Iraola-Truchuelo, Josu; Delgado, Javier; Perez, Ariadna; Guerreiro, Manuel; Caballero, Ana Carolina; Martinez-Cibrian, Nuria; Luzardo Henriquez, Hugo; Sanchez Pina, Jose Maria; Sancho, Juan-Manuel; Ghesquieres, Herve; Mussetti, Alberto; Lopez Corral, Lucia; Hernani, Rafael; Reguera, Juan Luis; Sureda, Anna; Bosch, Francesc; Martin Garcia-Sancho, Alejandro; Kwon, Mi; Subklewe, Marion; Kuhnl, Andrea; Bachy, Emmanuel; Barba, Pere; Villacampa, Guillermo; Abrisqueta, Pau
Rituximab maintenance after bendamustine-based treatment for follicular lymphoma and mantle cell lymphoma may exert a negative influence on SARS-CoV-2 infection outcomes
HAEMATOLOGICA
IF7.9
2024-07-112
OAAI
Serna, Angel; Navarro, Victor; Iacoboni, Gloria; Lopez, Laia; Sancho, Juan-Manuel; Gonzalez-Barca, Eva; Lopez-Garcia, Alberto; Cordoba, Raul; Saez, Adolfo; Jimenez-Ubieto, Ana; Ferrero, Ainara; Garcia, Tomas; Sanchez, Angela; Garcia, Cristina; Bosch, Marc; Cabirta, Alba; Jimenez, Moraima; Marin-Niebla, Ana; Bosch, Francesc; Abrisqueta, Pau
Ibrutinib followed by ofatumumab consolidation in previously untreated patients with chronic lymphocytic leukemia (CLL): GELLC-7 trial from the Spanish group of CLL (GELLC)

在先前未经治疗的慢性淋巴细胞白血病 (CLL) 患者中，依鲁替尼继之以ofatumumab巩固: 西班牙CLL组 (GELLC) 的GELLC-7试验

ECLINICALMEDICINE
IF10
2024-07-010
OAAI
Abrisqueta, Pau; Gonzalez-Barca, Eva; Ferra, Christelle; Rios-Herranz, Eduardo; de la Mata, Margarita Fernandez; Delgado, Julio; Andreu, Rafael; Hernandez-Rivas, Jose angel; Terol, Maria Jose; Navarro, Almudena; Vidriales, M. Belen; Baltasar, Patricia; De la Serna, Javier; Ramirez, Angel; Ballester, Carmen; Moreno, Carol; Garcia-Marco, Jose Antonio; Cordoba, Raul; Yanez, Lucrecia; Casado, Luis Felipe; Gonzalez, Marcos; Bosch, Francesc
Treatment outcomes in patients with large B-cell lymphoma after progression to chimeric antigen receptor T-cell therapy
HEMASPHERE
IF14.6
2024-05-212
OAAI
Iacoboni, Gloria; Iraola-Truchuelo, Josu; O'Reilly, Maeve; Navarro, Victor; Menne, Tobias; Kwon, Mi; Martin-Lopez, Ana africa; Chaganti, Sridhar; Delgado, Javier; Roddie, Claire; Perez, Ariadna; Norman, Jane; Guerreiro, Manuel; Gibb, Adam; Caballero, Ana Carolina; Besley, Caroline; Martinez-Cibrian, Nuria; Mussetti, Alberto; Sanderson, Robin; Luzardo, Hugo; Iyengar, Sunil; Sanchez, Jose Maria; Jones, Ceri; Sancho, Juan-Manuel; Barba, Pere; Latif, Anne-Louise; Lopez-Corral, Lucia; Hernani, Rafael; Reguera, Juan Luis; Sureda, Anna; Garcia-Sancho, Alejandro Martin; Bastos, Mariana; Abrisqueta, Pau; Kuhnl, Andrea
New therapies for relapsed or refractory aggressive B-cell lymphoma increase survival: Analysis from the RELINF registry of the GELTAMO group
HEMASPHERE
IF14.6
2024-04-220
OAAI
Bastos-Oreiro, Mariana; Abrisqueta, Pau; Gutierrez, Antonio; Ubieto, Ana Jimenez; Poza, Maria; Fernanez-Caldas, Paula; Llacer, Maria Jose; de Villambrosia, Sonia Gonzalez; Cordoba, Raul; Lopez, Alberto; Ceballos, Elena; Navarro, Belen; Muntanola, Ana; Donato, Eva; Diez-Baeza, Eva; Escoda, Lourdes; Luzardo, Hugo; Penarrubia, Maria Jose; Belmonte, Daniel Garcia; Pardal, Emilia; Lozada, Claudia; Garcia-Sancho, Alejandro Martin
A phase 1 study of JBH492, an anti C-C chemokine receptor 7 antibodydrug conjugate (anti-CCR7 ADC), assessing safety and efficacy in lymphoid malignancies
CANCER RESEARCH
IF16.6
2024-04-052
PRE
Abrisqueta, Pau; Marks, Reinhard; Avivi, Irit; Wermke, Martin; Lim, Francesca; Kim, Tae Min; Touzon, Alba Cabirta; Karihtala, Kristiina; Makita, Shinichi; Werner, Lillian; Tanaka, Chiaki; Dang, Anhthu; Chaudhury, Anwesha; Rice, Seth; Chowdhury, Rowshan; Knee, Deborah; Gomezcarrillo, Belen; Furutani, Elissa; Izutsu, Koji; Leppa, Sirpa
Polatuzumab vedotin plus rituximab and lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma: a cohort of a multicentre, single-arm, phase 1b/2 study
LANCET HAEMATOLOGY
IF17.7
2024-02-013
PRE
Abrisqueta, Pau; Gonzalez-Barca, Eva; Panizo, Carlos; Perez, Jose Maria Arguinano; Miall, Fiona; Bastos-Oreiro, Mariana; Triguero, Ana; Banerjee, Lalita; Mcmillan, Andrew; Seymour, Erlene; Hirata, Jamie; de Guzman, Jayson; Sharma, Sunil; Jin, Hyun Yong; Musick, Lisa; Diefenbach, Catherine
Impact of SCHOLAR-1 Criteria on Chimeric Antigen Receptor T Cell Therapy Efficacy in Aggressive B Lymphoma: A Real-World GELTAMO/ GETH Study

SCHOLAR-1标准对侵袭性B淋巴瘤嵌合抗原受体T细胞治疗疗效的影响: 一项真实世界的GELTAMO/ GETH研究

TRANSPLANTATION AND CELLULAR THERAPY
IF4.4
2023-12-010
OAAI
Bastos-Oreiro, Mariana; Gutierrez, Antonio; Iacoboni, Gloria; Corral, Lucia Lopez; Reguera, Juan Luis; Abrisqueta, Pau; Delgado, Javier; Terol, Maria Jose; Hernani, Rafael; Martinez, Nuria; Ortiz, Valentin; Bailen, Rebeca; Gomez-Centurion, Ignacio; Caballero, Ana; Sanz, Jaime; Dominguez, Luisa Guerra; Luzardo, Hugo; Mussetti, Alberto; Jimenez-Ubieto, Ana; Sancho, Juan Manuel; Sureda, Anna; Perez, Antonio; Barba, Pere; Kwon, Mi; Garcia-Sancho, Alejandro Martin
A low total metabolic tumor volume independently predicts for a longer time to first treatment in initially observed, low tumor burden follicular lymphoma
HEMATOLOGICAL ONCOLOGY
IF3.9
2023-11-094
OAAI
Mozas, Pablo; Casanueva-Eliceiry, Sebastian; Rivero, Andrea; Serna, Angel; Simo, Marc; Rodriguez, Sonia; Rivas-Delgado, Alfredo; Nadeu, Ferran; Correa, Juan Gonzalo; Pineyroa, Juan Antonio; Perez-Valencia, Amanda Isabel; Guinetti-Ortiz, Katia; Gomez-Hernando, Marta; Gine, Eva; Delgado, Julio; Villamor, Neus; Campo, Elias; Magnano, Laura; Abrisqueta, Pau; Setoain, Xavier; Lopez-Guillermo, Armando
Tafasitamab for patients with relapsed or refractory diffuse large B-cell lymphoma: final 5-year efficacy and safety findings in the phase II L-MIND study
HAEMATOLOGICA
IF7.9
2023-08-3113
OAAI
Duell, Johannes; Abrisqueta, Pau; Andre, Marc; Gaidano, Gianluca; Gonzales-Barca, Eva; Jurczak, Wojciech; Kalakonda, Nagesh; Liberati, Anna Marina; Maddocks, Kami J.; Menne, Tobias; Nagy, Zsolt; Tournilhac, Olivier; Kuffer, Christian; Bakuli, Abhishek; Amin, Aasim; Gurbanov, Konstantin; Salles, Gilles

研究方向

暂未获取到该数据
F
Francesc Bosch
H 指数:59论文数:495被引数:1.5万
M
Marta Crespo
H 指数:23论文数:113被引数:4,467
G
Gloria Iacoboni
H 指数:28论文数:191被引数:3,786
M
Mariana Bastos‐Oreiro
H 指数:20论文数:244被引数:1,572
C
Cecilia Carpio
H 指数:24论文数:155被引数:2,008
A
Alejandro Martı́n
H 指数:46论文数:497被引数:8,796
J
Josep Castellví
H 指数:43论文数:225被引数:5,897
J
Juan‐Manuel Sancho
H 指数:36论文数:406被引数:5,427
E
Eva González‐Barca
H 指数:44论文数:373被引数:7,155
M
María José Terol
H 指数:40论文数:284被引数:7,142